Table 1.
Procedure | Screening | Visit 1 (Day 0) Baseline | Visit 2 (Day 30) | Visit 3 (Day 60) | Visit 4 (Day 90) Final visit | Follow-Up visit (At least 15 days from the last visit) |
---|---|---|---|---|---|---|
Informed consent | X | |||||
Medical history | X | |||||
Physical examination | X | X | X | X | X | |
Demographicsa | X | X | X | X | X | |
Vital Signs | X | X | X | X | X | |
Haematology | X | X | ||||
Serum chemistry | X | X | ||||
Myeloperoxidaseb | X | X | ||||
Urine pregnancy testc | X | |||||
Randomisation | X | |||||
Investigational product dispensing | X | X | X | |||
Gastrointestinal discomfort questionnaire | X | X | X | X | ||
Irritable bowel syndrome quality of life questionnaire | X | X | X | X | ||
HAM-D scale | X | X | X | X | ||
MADRS | X | X | X | X | ||
CGI-I & CGI-S | X | X | X | X | ||
CES-D | X | X | X | X | ||
Dementia checklist | X | X | X | X | ||
Return of unused IP | X | X | X | |||
Adverse events | X | X | X | X | X | |
Concomitant medications | X | X | X | X | X | X |
HAM-D, Hamilton Rating Scale for Depression; MADRS, Montgomery–Asberg Depression Rating Scale; CGI-I & CGI-S, Clinical Global Impression-Improvement Rating Scale and Clinical Global Impression Severity Rating Scale; CES-D, Center for Epidemiological Studies Depression Scale.
Age at screening only.
Only for randomised subjects.
Urine pregnancy test at screening and on early termination, if any.